▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #17 by analyst upside · 2026-06-27
JSPR
Jasper Therapeutics, Inc.
Healthcare · Market Cap $10M · P/E 0x
ANALYST PRICE TARGET
+2429.3%
implied upside to consensus target
Current Price $0.34
Consensus Target $8.62
Bull Target $20.0
Bear Target $1.5
Analysts Covering 4
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
2
Hold
2
Sell
0
52-Week Low $0.34
52-Week High $7.19
YTD Return -81.5%
FUNDAMENTALS
Market Cap $10M
P/E Ratio (TTM) N/A
Forward P/E -0.1x
EPS (TTM) $-2.58
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.34
52-Week High $7.19
Current Price $0.34
Bear Target $1.5
Bull Target $20.0
● Now $0.34 ● Target $8.62
TRADING DATA
Avg Volume 553K
YTD Return -81.5%
Analyst Count 4
Consensus Buy
Upside to Target +2429.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Jasper Therapeutics, Inc. (JSPR) is currently trading at $0.34 with a Wall Street consensus price target of $8.62, implying potential upside of 2429.3% over the next 12 months. 4 analysts currently cover JSPR, with a consensus rating of Buy — 60% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.0, while the most cautious has a target of $1.5.

JSPR operates in the Healthcare sector with a market capitalisation of $10M. The stock is down 81.5% year-to-date and is currently trading near the lower end of its 52-week range of $0.34 – $7.19.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

OSRH +2894.0%
OSR Health, Inc.
$12M · P/E 11.1x · Hold
PSTV +757.1%
Plus Therapeutics, Inc.
$29M · P/E 0.2x · Buy
DWTX +748.5%
Dogwood Therapeutics, Inc.
$55M · P/E 1.4x · Strong Buy
ETST +566.7%
Earth Science Tech, Inc.
$43M · P/E 15.0x · Hold
VXRT +488.2%
Vaxart, Inc.
$123M · P/E 3.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for JSPR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen ↓ Downgrade
Buy → Hold 2026-05-15 Building track record
RBC Capital — Reiterated
Sector Perform → Sector Perform 2026-05-15 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-04-01 Building track record
RBC Capital — Reiterated
Sector Perform → Sector Perform 2025-11-11 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2025-09-22 Building track record
JMP Securities — Reiterated
Market Outperform → Market Outperform 2025-09-22 Building track record
BTIG — Reiterated
Buy → Buy 2025-09-22 38% win rate (8 calls)
UBS — Reiterated
Buy → Buy 2025-08-15 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →